Consumer
The Gamble Behind a Takeover of Kenvue, Maker of Tylenol
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they're manageable.
Company
KVUE
Kenvue
No market stories in the last 7 days. The latest coverage is below.
- 7-day mood
- —Not enough data
- Stories, 7 days
- 0
- Last 24 hours
- 0no baseline yet
- Sources
- 14in the latest 30
Mood and coverage · last 7 days
Market chart- Kenvue · 6-hour average
- Hourly reading
- Stories per hour
No scored stories in the last 7 days.
View as table
| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
Latest on Kenvue
Newest firstConsumer
Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal
Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for cons…
Consumer
Kimberly-Clark to buy Tylenol maker Kenvue for nearly $50 billion
Manufacturing giant Kimberly-Clark is set to acquire Kenvue, the maker of Tylenol, for $48.7 billion. CBS News MoneyWatch correspondent Kelly O'Grady has more…
Consumer
Stocks making the biggest moves midday: Amazon, Adeia, Kenvue, Iren & more
These are the stocks posting the largest moves midday.
Consumer
Huggies maker Kimberly-Clark is buying Tylenol maker Kenvue
One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common painkiller to autism, which the co…
Consumer
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Markets
Stocks making the biggest moves premarket: Iren, Kenvue, Cipher Mining, New Gold and more
These are some of the stocks posting the largest moves in premarket trading.
Consumer
Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion
Kenvue's stock, which had hit a record low in recent weeks, was headed for its best day ever while Kimberly-Clark's stock tumbled.
Consumer
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company
Consumer
Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.
Consumer
Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.
Consumer
Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion
The owner of Kleenex and Huggies will acquire the embattled company, which has fought claims by the Trump administration that a common pain reliever is linked…
Healthcare
We Have Our First Major Tylenol Lawsuit
Texas Attorney General Ken Paxton is suing the makers of Tylenol for marketing the drug to pregnant mothers despite allegedly knowing that early exposure to th…
Consumer
Research tying Tylenol to autism lost in court. Then it won Trump's ear.
Kenvue had gained the upper hand in litigation alleging acetaminophen use during pregnancy can cause autism. Now the Trump administration has breathed new life…
Crypto
Trading meme stocks, gold, and crypto, Kenvue's stock rebounds
Trading meme stocks, gold, and crypto, Kenvue's stock rebounds
Healthcare
Tylenol maker rebounds a day after Trump's unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discred…
Markets
Stocks making the biggest moves premarket: Firefly Aerospace, AutoZone, Kenvue & more
These are the stocks posting the largest moves in early trading.
Markets
Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link
Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn't offer fresh evidence that could be used by plaintiffs to sue the…
Consumer
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between…
Markets
Kenvue says Tylenol is safe, but stock hits record low ahead of Trump speech
Kenvue's stock was heading for a record low as investors express concerns over what President Trump will say regarding the use of acetaminophen - the active in…
Technology
Stocks making the biggest moves midday: Oracle, Apple, Metsera, Compass, Kenvue and more
See which stocks are posting big moves in midday trading.
Markets
Stocks making the biggest premarket moves: Metsera, Compass, Kenvue, Fox and more
See which stocks are posting big moves before the bell.
Markets
Kenvue fights back against RFK Jr.'s Tylenol safety concerns as its stock tumbles
Kenvue rushed to the defense of Tylenol, but the stock still suffered a record selloff on news that RFK Jr. will release a report linking the use of acetaminop…
Markets
Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy
HHS will release the report that could draw that link between the pain medication and autism this month, according to the Wall Street Journal.
Consumer
Interesting KVUE Put And Call Options For December 2027
Investors in Kenvue Inc (Symbol: KVUE) saw new options begin trading today, for the December 2027 expiration. One of the key inputs that goes into the price an…
Markets
KVUE Quantitative Stock Analysis
Below is Validea's guru fundamental report for KENVUE INC (KVUE). Of the 22 guru strategies we follow, KVUE rates highest using our Multi-Factor Investor model…
Markets
Stocks making the biggest moves premarket: Kenvue, Rivian, Affirm, SolarEdge Technologies and more
These are some of the stocks posting the largest moves in premarket trading.
Geopolitics
Benadryl, Band-Aid parent says tariffs and late allergy season are hurting its business
Kenvue CEO Thibaut Mongon says consumers are under pressure and worried about the economy
Markets
Kenvue Earnings Preview: What to Expect
Kenvue is set to unveil its Q1 results in the upcoming month, and analysts expect a notable decline in earnings.
Autos
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
These are the stocks posting the largest moves in midday trading.
